Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
LSCC - Lattice Semiconductor Corp. - Stock Price Chart
TickerLSCC [NASD]
CompanyLattice Semiconductor Corp.
CountryUSA
IndustrySemiconductors
Market Cap9.44BEPS (ttm)1.56
P/E43.88EPS this Y-41.38%
Forward P/E40.81EPS next Y42.67%
PEG6.49EPS past 5Y-
P/S13.60EPS next 5Y6.76%
P/B13.61EPS Q/Q-73.30%
Dividend-Sales Q/Q-23.60%
Insider Own1.31%Inst Own109.66%
Insider Trans-15.02%Inst Trans-3.13%
Short Float9.56%EarningsApr 29/a
Analyst Recom1.92Target Price79.88
Avg Volume2.19M52W Range51.96 - 98.30
Lattice Semiconductor Corp. engages in the business of developing technologies that are monetized through differentiated programmable logic semiconductor products, system solutions, design services, and licenses. The firm also offers silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The company was founded in 1983 and is headquartered in Hillsboro, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luther Sherri RSVP, CFOFeb 27 '24Sale74.7823,0061,720,342124,116Feb 28 01:44 PM
O'Rourke GlennSVP, Mfg OpsFeb 26 '24Sale75.138,594645,6370Feb 27 01:49 PM
Feanny Tracy AnnSVP, General CounselFeb 26 '24Sale75.146,318474,72511,908Feb 27 01:50 PM
ANDERSON JAMES ROBERTPresident, CEOFeb 22 '24Sale73.4758,8084,320,835785,055Feb 23 03:44 PM
O'Rourke GlennSVP, Mfg OpsFeb 22 '24Sale73.4725,3281,860,8408,594Feb 23 03:47 PM
ABVC - ABVC BioPharma Inc - Stock Price Chart
TickerABVC [NASD]
CompanyABVC BioPharma Inc
CountryUSA
IndustryBiotechnology
Market Cap13.20MEPS (ttm)-2.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.78%
P/S88.00EPS next 5Y-
P/B1.12EPS Q/Q73.75%
Dividend-Sales Q/Q-99.63%
Insider Own17.84%Inst Own1.05%
Insider Trans0.00%Inst Trans-81.20%
Short Float6.14%EarningsNov 15/b
Analyst Recom3.00Target Price20.20
Avg Volume1.11M52W Range0.67 - 9.60
Apr-18-24 09:25AM AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share (GlobeNewswire)
Apr-17-24 09:00AM ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M (GlobeNewswire) -8.93%
Apr-10-24 08:30AM ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M (GlobeNewswire)
Mar-26-24 08:30AM ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M (GlobeNewswire) +21.90%
Mar-21-24 08:30AM AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars (GlobeNewswire)
Mar-19-24 08:30AM ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine (GlobeNewswire)
Mar-14-24 09:30AM ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update (GlobeNewswire)
Feb-27-24 08:30AM ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars (GlobeNewswire)
Feb-15-24 08:30AM ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues (GlobeNewswire)
Feb-12-24 08:30AM ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD) (GlobeNewswire)
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
FBLG - FibroBiologics Inc - Stock Price Chart
TickerFBLG [NASD]
CompanyFibroBiologics Inc
CountryUSA
IndustryBiotechnology
Market Cap308.55MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B212.48EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own18.87%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.02%Earnings-
Analyst Recom-Target Price-
Avg Volume96.76K52W Range6.53 - 55.00
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm's product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O'Heeron on April 8, 2021 and is headquartered in Houston, TX.
STLA - Stellantis N.V - Stock Price Chart
TickerSTLA [NYSE]
CompanyStellantis N.V
CountryNetherlands
IndustryAuto Manufacturers
Market Cap64.09BEPS (ttm)6.40
P/E3.48EPS this Y-15.34%
Forward P/E3.81EPS next Y0.04%
PEG-EPS past 5Y18.67%
P/S0.31EPS next 5Y-6.45%
P/B0.75EPS Q/Q6.13%
Dividend7.52%Sales Q/Q3.85%
Insider Own29.19%Inst Own30.38%
Insider Trans0.00%Inst Trans-
Short Float0.68%EarningsApr 30/b
Analyst Recom1.93Target Price29.62
Avg Volume5.76M52W Range15.07 - 29.51
Stellantis NV engages in the design, manufacture, distribution, and sale of vehicles. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroen, Dodge, DS, Fiat, Fiat Professional, Jeep, Lancia, Opel, Peugeot, Ram, and Vauxhall brands. The company was founded on April 01, 2014 and is headquartered in Hoofddorp, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stellantis N.V.10% OwnerMar 15 '24Buy5.19750,0003,894,05339,351,720Mar 18 04:17 PM
Stellantis N.V.10% OwnerMar 14 '24Buy4.99750,0003,743,24938,601,720Mar 18 04:17 PM
Stellantis N.V.10% OwnerMar 13 '24Buy5.36800,0004,286,00037,851,720Mar 14 04:45 PM
Stellantis N.V.10% OwnerMar 12 '24Buy4.98800,0003,984,95137,051,720Mar 14 04:45 PM
Stellantis N.V.10% OwnerMar 11 '24Buy4.83800,0003,862,40036,251,720Mar 12 05:07 PM
RIG - Transocean Ltd - Stock Price Chart
TickerRIG [NYSE]
CompanyTransocean Ltd
CountrySwitzerland
IndustryOil & Gas Drilling
Market Cap4.28BEPS (ttm)-0.52
P/E-EPS this Y91.63%
Forward P/E14.48EPS next Y548.80%
PEG-EPS past 5Y21.86%
P/S1.45EPS next 5Y-
P/B0.41EPS Q/Q117.22%
Dividend-Sales Q/Q17.57%
Insider Own12.01%Inst Own68.71%
Insider Trans2.07%Inst Trans2.87%
Short Float17.96%EarningsApr 29/a
Analyst Recom2.40Target Price7.07
Avg Volume18.98M52W Range4.45 - 8.88
Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THIGPEN JEREMY DCEOMar 01 '24Option Exercise5.09941,1924,790,6675,551,127Mar 05 07:10 PM
Mey Mark-Anthony LovellEVP & CFOMar 01 '24Option Exercise5.09325,8051,658,3471,724,606Mar 05 07:12 PM
Adamson KeelanPRESIDENT AND COOMar 01 '24Option Exercise5.09312,5101,590,6761,144,550Mar 05 07:13 PM
DAVIS HOWARD EEVP, CAO & CIOMar 01 '24Option Exercise5.09259,4371,320,5341,529,840Mar 05 07:15 PM
Long Brady KEVP & GENERAL COUNSELMar 01 '24Option Exercise5.09254,4931,295,3691,547,974Mar 05 07:17 PM
HIVE - HIVE Digital Technologies Ltd. - Stock Price Chart
TickerHIVE [NASD]
CompanyHIVE Digital Technologies Ltd.
CountryCanada
IndustryCapital Markets
Market Cap265.68MEPS (ttm)-0.64
P/E-EPS this Y76.24%
Forward P/E-EPS next Y-23.13%
PEG-EPS past 5Y-32.45%
P/S2.77EPS next 5Y-
P/B1.31EPS Q/Q92.76%
Dividend-Sales Q/Q118.26%
Insider Own0.49%Inst Own24.83%
Insider Trans0.00%Inst Trans-
Short Float5.52%EarningsFeb 13/b
Analyst Recom2.00Target Price4.75
Avg Volume2.82M52W Range2.53 - 6.84
HIVE Digital Technologies Ltd. engages in building a bridge from the block chain sector to traditional capital markets. It also involves in the production of mined cryptocurrency like Ethereum around the clock. Its project include Iceland Cryptocurrency Mining. The company was founded on June 24, 1987 and is headquartered in Vancouver, Canada.
PROK - ProKidney Corp - Stock Price Chart
TickerPROK [NASD, RUT]
CompanyProKidney Corp
CountryUSA
IndustryBiotechnology
Market Cap127.25MEPS (ttm)-0.57
P/E-EPS this Y-66.75%
Forward P/E-EPS next Y35.14%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q9.68%
Dividend-Sales Q/Q-
Insider Own29.67%Inst Own57.35%
Insider Trans-33.76%Inst Trans2.18%
Short Float26.67%EarningsMar 21/a
Analyst Recom1.80Target Price4.20
Avg Volume740.64K52W Range1.12 - 13.51
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Darin J.SVP of Regulatory DevelopmentApr 22 '24Sale2.5116,43841,315155,194Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 18 '24Sale2.548002,028171,632Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 16 '24Sale2.5017,23843,095172,432Apr 17 06:57 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 12 '24Sale1.7384,103145,498189,670Apr 16 04:54 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 01 '24Sale1.69300507273,773Apr 16 04:54 PM
BAER - Bridger Aerospace Group Holdings Inc - Stock Price Chart
TickerBAER [NASD]
CompanyBridger Aerospace Group Holdings Inc
CountryUSA
IndustrySecurity & Protection Services
Market Cap190.47MEPS (ttm)-0.42
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.86EPS next 5Y-
P/B-EPS Q/Q-8.75%
Dividend-Sales Q/Q-0.40%
Insider Own0.00%Inst Own2.33%
Insider Trans-Inst Trans-
Short Float0.47%EarningsMar 19/a
Analyst Recom-Target Price-
Avg Volume21.66K52W Range3.80 - 9.19
Bridger Aerospace Group Holdings, Inc. engages in the provision of aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its fleet includes Daher Kodiak 100, Twin Commander, Pilatus PC-12, DeHaviland Twin Otter 300, and De Havilland CL-415EAF. The company was founded by Timothy Sheehy and Matthew P. Sheehey in 2014 and is headquartered in Belgrade, MT.
SHLT - SHL Telemedicine Ltd. ADR - Stock Price Chart
TickerSHLT [NASD]
CompanySHL Telemedicine Ltd. ADR
CountryIsrael
IndustryHealth Information Services
Market Cap79.66MEPS (ttm)-0.43
P/E-EPS this Y31.58%
Forward P/E-EPS next Y100.00%
PEG-EPS past 5Y-
P/S1.40EPS next 5Y-
P/B1.08EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own3.86%
Insider Trans-Inst Trans-
Short Float-EarningsApr 17/b
Analyst Recom1.00Target Price11.00
Avg Volume4.18K52W Range4.85 - 12.75
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.
CRML - Critical Metals Corp. - Stock Price Chart
TickerCRML [NASD]
CompanyCritical Metals Corp.
CountryUSA
IndustryOther Industrial Metals & Mining
Market Cap98.28MEPS (ttm)-0.02
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.84EPS Q/Q-493.10%
Dividend-Sales Q/Q-
Insider Own17.67%Inst Own29.69%
Insider Trans0.00%Inst Trans-0.45%
Short Float0.81%Earnings-
Analyst Recom-Target Price-
Avg Volume51.87K52W Range5.32 - 22.50
Apr-22-24 04:15PM Critical Metals Appoints Tony Sage as Chief Executive Officer (GlobeNewswire) +11.36%
Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns the Wolfsberg Lithium Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.
123456789101120